ImetelChat

Zhears - These 50 New positions with a salary in the $175-185,000 range translates to approx $9-10M/yr. While a fairly sizeable amount, it pales in comparison to the approx $200M/yr current burn rate. As shareholders let's all hope we get a partnership at some point in the very near future. I think ...

50 New positions posted today - From Seattle to Miami, and everywhere in-between - all "Oncology Key Account Managers".........looks like something is brewing? -Kmall https://workforcenow.adp.com/mascsr/default/mdf/recruitment/recruitment.html?cid=a69f1432-af4c-471b-88c8-44c7c81587aa&ccId=19000101_0...

Ryan - This latest hire is based in Chicago and was at Abbvie for 3yrs......2+ as Manager, Global Strategies. Abbvie has been on an acquisition frenzy the past 2 months......not that it means anything here, but you never know? -Kmall

Geron has recently added a Sr. Director/Legal Counsel who started her career with the FDA. Perhaps this helps with the MA lock? -Kmall

Interesting look at the Abbvie bidding war for Immunogen -Kmall

https://www.fiercepharma.com/pharma/ins ... war-it-won

Interesting that China is noted in the time zone announcement times - the others are FDA, EMA and UK based.......not sure if this amounts to anything? Regardless, nice pull RC -Kmall

Bp - Thanks for the synopsis on this editorial, great insight! Going waaaayyy back to April 2019 and the Needham Healthcare Conference, where Dr. Rizo was publicly introduced, Dr. Scarlett mentioned side effects and in particular: "They understand how to manage the drug in regards in cytopenias" Dir...

It's been two years tomorrow since Ed Koval signed on as CBO...... "I am excited to be joining this exceptional executive team and look forward to contributing to Geron becoming a leader in the treatment of hematologic malignancies, and to maximizing the value of imetelstat for patients, physicians ...

Abecma - Bristol Meyers Squibb (Celgene) Breyanzi - Bristol Meyers Squibb Carvykti - JNJ (Janssen) Kymriah - Novartis Tecartus - Gilead (Kite Pharma) Yescarta - Gilead (Kite Pharma) https://www.fiercepharma.com/pharma/fda-investigates-serious-risk-secondary-cancer-following-car-t-therapy-treatment W...

Looks like Vivo is currently sitting on 26.9M shares of Geron.....up from 22.8M - interesting that they make a point of him being an independent board member? -Kmall

https://fintel.io/so/us/gern

It's all about the pipeline.......

https://www.ft.com/content/ffce99b0-7fd ... d03cd68882

Kazarius over on the YMB posted this earlier this morning......great video featuring Dr. Ronald Hoffman of Mt. Siani in NYC......Kaz, thanks for pointing this and Dr. Hoffman's background out, something tells me it won't stay up long on the YMB...... Fantastic dig!!! -Kmall https://m.youtube.com/wat...

It's a good time to reflect and give THANKS to all of those Clinical Trial patients; past, present and future, who have courageously sacrificed to propel Imetelstat to the brink of approval. -Kmall

Bp - Being a private subsidiary of Bayer, I'm not aware of any inducement options being made public?

If they hold Bayer stock - and I'm fairly certain they do - today wouldn't be a good day to be selling. -Kmall

Bp - Fairly certain inducement grants were vested for each since their "employment" terms surpassed the 4yr limit. It appears (speculation time) that they both were tied to the FDA NDA acceptance since that announcement was in August. Perhaps any "consultation" role over the June (FDA submission) to...

As of September of this year, both Laurie Sherman and Dr. Rizo are solely Vividion/Bayer employees......they are no longer with Geron. -Kmall

Yup, competition is/has been the 800lb gorilla in the room....posted about this last year, right after ASH 2022. "In the announcement accompanying the results, the Tisch Cancer Institute in New York adult leukaemia programme director John Mascarenhas said: “The pelabresib and ruxolitinib combination...

Anyone notice Bayer taking a 17+% hit today ?? A new 12yr low. Last I checked more than $8B wiped out.....just today..... ouucchh!!! https://www.reuters.com/business/healthcare-pharmaceuticals/bayer-cancels-asundexian-phase-iii-study-program-2023-11-20/ If they are a contender they better act quick....

Ryan - I tried....

Gene Gene the Dancing Machine didn't work....

Maybe the unknown comic will do the trick? -Kmall


https://youtu.be/Xj3Q9l9Ivng?si=q8R6sTQP0nBJYJOy

It's officially Gong Show time.......

https://youtu.be/xuJHKVQ2kLA?si=s8fmIVqF_gbEr2zZ

-Kmall